Skip to main content
TipRanks
Go Ultimate75% OFF

Mannatech (MTEX) AI Stock Analysis

78 Followers
MTEX

Mannatech

(NASDAQ:MTEX)

Select Model
Rating:37Underperform
Price Target:$3.50â–²(23.67% Upside)
Action:downgraded
Date:11/17/26

The overall score is at the lowest possible level, reflecting a high-risk profile. The most significant factor is the company's severely deteriorated financial health, marked by persistent revenue declines, negative cash flow, and a recently insolvent balance sheet. This is compounded by deeply bearish technicals, with the stock in a sustained downtrend and oversold conditions, and a negative P/E ratio that underscores the lack of current profitability.

Positive Factors
High Gross MarginsStable gross margins provide a durable base for profitability because the company retains substantial revenue after product costs. If revenue and operating execution improve, this margin structure could support stronger earnings conversion without requiring a fundamental change to the product portfolio.
Negative Factors
Persistent Revenue DeclineMulti-year revenue contraction suggests weakening demand or distribution momentum rather than a temporary fluctuation. Continued top-line erosion can reduce operating leverage, limit reinvestment capacity, and make the company’s otherwise high gross margins less valuable to long-term earnings generation.

Mannatech (MTEX) vs. SPDR S&P 500 ETF (SPY)

-80%-60%-40%-20%0%20%MTEX-70.79%SPY+11.73%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$7.26M
Dividend Yield
―
Average Volume (3M)
36.07K
Price to Earnings (P/E)
-12.9
Beta (1Y)
0.58
Revenue Growth
-6.65%
EPS Growth
64.09%
Country
US
Employees
170
Sector
Consumer Defensive
Sector Strength
62
Industry
Food Distribution

Mannatech Business Overview & Revenue Model

Company Description

Mannatech, Incorporated operates as a global enterprise focused on health and wellness. The company specializes in the creation, marketing, and distribution of a diverse range of products, including dietary supplements, topical skincare and anti-agin...

Mannatech Financial Statement Overview

Summary

Financial performance is critically weak. Revenue has persistently declined, the company swung to a net loss, and the balance sheet was recently insolvent with negative equity. Cash flow is negative, indicating the business is consuming cash. The TTM period shows only tentative stabilization from a very low base.

Income Statement

35Negative

Balance Sheet

18Very Negative

Cash Flow

22Negative
Financial statement breakdown
BreakdownTTMMar 2026Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue103.07M108.04M117.87M131.96M137.21M159.76M
Gross Profit77.98M80.96M91.46M102.86M104.15M125.61M
EBITDA1.83M-1.39M5.55M498.00K1.15M10.61M
Net Income-425.00K-15.21M2.49M-2.24M-4.49M9.84M
Balance Sheet
Total Assets27.90M29.99M36.06M41.21M49.13M59.63M
Cash, Cash Equivalents and Short-Term Investments5.42M6.18M11.40M7.73M13.78M24.18M
Total Debt6.29M7.36M6.69M5.71M6.21M1.83M
Total Liabilities22.70M35.22M27.44M30.72M34.95M35.21M
Stockholders Equity5.20M-5.22M8.61M10.48M14.18M24.41M
Cash Flow
Free Cash Flow-648.00K-4.32M1.96M-3.12M-3.66M10.12M
Operating Cash Flow-204.00K-2.96M2.26M-2.37M-2.60M10.77M
Investing Cash Flow-444.00K-1.35M-285.00K-747.00K-1.06M-650.00K
Financing Cash Flow-288.00K-561.00K1.96M-1.90M-4.33M-9.29M

Mannatech Technical Analysis

Technical Analysis SentimentNegative
Last Price2.83

Price Trends

50DMA7.77Negative
100DMA6.68Negative
200DMA6.27Negative

Market Momentum

MACD-0.65Positive
RSI22.15Positive
STOCH0.16Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MTEX, the sentiment is Negative. The current price of 2.83 is below the 20-day moving average (MA) of 7.88, below the 50-day MA of 7.77, and below the 200-day MA of 6.27, indicating a bearish trend. The MACD of -0.65 indicates Positive momentum. The RSI at 22.15 is Positive, neither overbought nor oversold. The STOCH value of 0.16 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MTEX.

Mannatech Risk Analysis

Mannatech disclosed 41 risk factors in its most recent earnings report. Mannatech reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.Our profitability and market competitiveness may be adversely impacted by changes in trade policies, including tariffs or other factors.Q3, 2026
2.Our profitability and market competitiveness may be adversely impacted by changes in trade policies, including tariffs or other factors.Q2, 2026
3.Our profitability and market competitiveness may be adversely impacted by changes in trade policies, including tariffs or other factors.Q1, 2026

Mannatech Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

MTEX against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
SKINSKIN54Neutral$98.46M-5.32-32.09%―-4.41%-51.42%
EPCEPC51Neutral$1.31B-24.92-3.53%2.11%-10.21%-310.40%
TKLFTKLF43Neutral$5.71M0.821.71%15.10%77.22%-89.32%
NUSNUS41Neutral$191.30M-0.81-34.83%6.11%-15.27%-318.35%
MTEXMTEX37Underperform$7.26M-12.8916.12%―-6.65%64.09%

* Consumer Defensive Sector Average

Performance Comparison

-50%0%50%MTEXNUSEPCSKINTKLFDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
MTEX and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MTEXMannatech Inc2.83-6.63-70.08%
NUSNu Skin Enterprises3.78-5.41-58.86%
EPCEdgewell Personal Care Co27.9711.0365.09%
SKINBeauty Health Company13.88-11.93-46.22%
TKLFYoshitsu Co. Ltd. Sponsored ADR1.44-1.31-47.63%

Mannatech Corporate Events

Business Operations and StrategyDelistings and Listing ChangesFinancial DisclosuresRegulatory Filings and Compliance

Mannatech Restores Nasdaq Compliance Through Swiss Tax Ruling

Neutral
Oct 14, 2026

On April 20, 2026, Mannatech received a notice from Nasdaq that it was not in compliance with the minimum $2.5 million stockholders’ equity requirement for continued listing on the Nasdaq Capital Market, after reporting negative equity of $5.2 millio...

Business Operations and StrategyExecutive/Board Changes

Mannatech Appoints Robert Toth as New Board Chairman

Positive
Sep 1, 2026

On September 1, 2026, Mannatech announced the retirement of long-serving chairman J. Stanley Fredrick from its board of directors, following his August 26, 2026 notice to step down for personal reasons. Fredrick, who joined the board in 2001 and has...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 17, 2026